Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Revolution Medicines’ Acquisition of EQRx
Renesas Electronics Corporation’s $249 Million Acquisition of Sequans Communications
Goodwin advised Renesas Electronics Corporation, and Orrick advised Sequans. Renesas Electronics Corporation (TSE: 6723) and Sequans Communications S.A. (NYSE: SQNS) announced that the two companies have entered...
Coherus’ Acquisition of Surface Oncology
Arnold & Porter advised Coherus Biosciences Inc. on the deal, and Goodwin advised Surface Oncology. Coherus Biosciences Inc. (Coherus) announced its acquisition of Surface Oncology Inc. (Surface),...
E. & J. Gallo Winery’s Acquisition of Bev
Goodwin advised Bev on the deal. E. & J. Gallo Winery announced that it acquired Bev and its portfolio of premium canned wines and spritzers. The acquisition...
Latch’s Acquisition of Honest Day’s Work
Goodwin advised Honest Day’s Work on the deal. Latch, Inc. (NASDAQ: LTCH) announced that it has entered into a definitive agreement to acquire Honest Day’s Work...
Subject Matter’s Acquisition of Kivvit
Goodwin Procter advised Subject Matter, and Seyfarth Shaw advised Kivvit. Subject Matter, a portfolio company of Coral Tree Partners, announced its acquisition of Kivvit to create...
Uwill’s $30 Million Series A Funding Round
Goodwin advised Education Growth Partners on its investment. Uwill announced it has completed a $30 million Series A funding round. The investment further cements Boston-based Uwill...
Magenta Therapeutics’ Merger with Dianthus Therapeutics
Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...
Weaviate.io’s $50 Million Series B Funding Round
Goodwin Procter advised Weaviate.io on the deal. Weaviate.io announced its $50 million Series B funding round led by Index Ventures with participation from Battery Ventures. Weaviate’s existing...
JMI Equity’s $90 Million Investment in Coursedog
Goodwin Procter advised JMI Equity on the deal. JMI Equity announced its $90 million strategic growth investment in Coursedog. JMI Equity is a growth equity firm focused...
Berkshire Grey’s Merger Agreement with SoftBank Group
Goodwin advised Berkshire Grey, Inc. on the deal. Berkshire Grey, Inc. (Nasdaq: BGRY) announced its definitive merger agreement to be acquired by SoftBank Group Corp. and its...
Mirion Technologies’ $85.6 Million Secondary Offering
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...